F-group (family)
2004.1.1.17 Myosin_head
Ligands and drugs
936
Member domains
226
with ligand contacts (≤ 4 Å)
24.1% of members
179
with DrugDomain annotations
19.1% of members
147
with a DrugBank compound
15.7% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 2004.1.1.17 belongs to X-group 2004 P-loop domains-like, which binds 7.5 ligand superclasses per 20 proteins, narrower than 53% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB16833 | ADP | Adenosine disphosphate | 109 |
| DB04444 | ALF | Tetrafluoroaluminate Ion | 16 |
| DB01944 | BIT | (S)-blebbistatin | 6 |
| DB11816 | 2OW | Omecamtiv Mecarbil | 4 |
| DB02930 | AGS | Adenosine 5'-[gamma-thio]triphosphate | 3 |
| DB02379 | BGC | Beta-D-Glucose | 2 |
| DB03126 | MNT | Mant-Adp | 2 |
| DB03434 | MPO | 3-(N-morpholino)propanesulfonic acid | 2 |
| DB03900 | TBU | tert-butanol | 2 |
| DB04349 | PGO | (S)-propane-1,2-diol | 2 |
| DB07468 | BL4 | (3aS)-3a-hydroxy-5-methyl-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one | 2 |
| DB07469 | BL6 | (3aS)-3a-hydroxy-7-methyl-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one | 2 |
| DB07470 | BL7 | (3aS)-3a-hydroxy-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one | 2 |
| DB08276 | NMQ | trifluoro-[hydroxy-[hydroxy-[2-(N-methyl-2-nitro-anilino)ethoxy]phosphoryl]oxy-phosphoryl]oxy-beryllium(1-) | 2 |
| DB08378 | PDM | 4-[4-(2,5-DIOXO-PYRROLIDIN-1-YL)-PHENYLAMINO]-4-HYDROXY-BUTYRIC ACID | 2 |
| DB00171 | ATP | ATP | 1 |
| DB02210 | HEZ | Hexane-1,6-Diol | 1 |
| DB02709 | STL | Resveratrol | 1 |
| DB03366 | — | Imidazole | 1 |
| DB03709 | BCN | Bicine | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| MGmetal | MAGNESIUM ION | 180 |
| ADP | ADENOSINE-5'-DIPHOSPHATE | 153 |
| VO4 | VANADATE ION | 41 |
| BEF | BERYLLIUM TRIFLUORIDE ION | 20 |
| ALF | TETRAFLUOROALUMINATE ION | 15 |
| ANP | PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER | 14 |
| 2OW | methyl 4-(2-fluoro-3-{[(6-methylpyridin-3-yl)carbamoyl]amino}benzyl)piperazine-1-carboxylate | 10 |
| AD9 | ADP METAVANADATE | 10 |
| XB2 | Mavacamten | 8 |
| BIT | (-)-1-PHENYL-1,2,3,4-TETRAHYDRO-4-HYDROXYPYRROLO[2,3-B]-7-METHYLQUINOLIN-4-ONE | 5 |
| AGS | PHOSPHOTHIOPHOSPHORIC ACID-ADENYLATE ESTER | 4 |
| AOV | ADP ORTHOVANADATE | 4 |
| 52E | 4-{[(2-chloro-3-fluorobenzyl)carbamoyl](methyl)amino}-3,4-dideoxy-5-O-(isoquinolin-3-ylcarbamoyl)-D-erythro-pentitol | 2 |
| 6I6 | aficamten | 2 |
| A1IGE | (3~{a}~{S})-1-(2-methoxypyridin-4-yl)-6,7-dimethyl-3~{a}-oxidanyl-2,3-dihydropyrrolo[2,3-b]quinolin-4-one | 2 |
| BGC | beta-D-glucopyranose | 2 |
| CL | CHLORIDE ION | 2 |
| KQ0 | 1-(4-methoxyphenyl)-~{N}-[(3-thiophen-2-yl-1~{H}-pyrazol-4-yl)methyl]cyclopropan-1-amine | 2 |
| MNmetal | MANGANESE (II) ION | 2 |
| MPO | 3[N-MORPHOLINO]PROPANE SULFONIC ACID | 2 |